Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years - Biology of Blood and Marrow Transplantation
Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis - Annals of Oncology
TRM, Relapse/Progression (1a), Progression Free and Overall Survival... | Download Scientific Diagram
Five-year overall survival (OS) estimates (A) and 2-year cumulative... | Download Scientific Diagram
Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia | Anales de Pediatría
Overall survival (OS) in elderly AML patients a OS according to period;... | Download Scientific Diagram
Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults | Blood Cancer Journal
Overall survival (OS) amongst patients with AL amyloidosis undergoing... | Download Scientific Diagram
Overall survival (OS) and relative survival by treatment intensity and... | Download Scientific Diagram
Prognostic benefit of stromal and epithelial CD8CD103 TRM infiltration... | Download Scientific Diagram
Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation | SpringerLink
Survival following allogeneic transplant in patients with myelofibrosis - ScienceDirect
Relapse-free survival (RFS) and overall survival (OS). Kaplan-Meier... | Download Scientific Diagram
Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial - Lung Cancer
Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years - Biology of Blood and Marrow Transplantation
Cumulative incidence of cGVHD, transplant-related mortality (TRM),... | Download Scientific Diagram
Outcomes by FLT3-ITD and NPM1 status LFS (a), OS (b), TRM (c), and RI... | Download Scientific Diagram
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial - ScienceDirect
Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC - ScienceDirect
Favorable Overall Survival with Fully Myeloablative Allogeneic Stem Cell Transplantation for Follicular Lymphoma - Biology of Blood and Marrow Transplantation
